Torben Schiffner

Cell entry mechanisms of SARS-CoV-2

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

Native‐like Env trimers as a platform for HIV‐1 vaccine design

Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies

Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies

Messenger RNA-Based Vaccines Against Infectious Diseases

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

HIV–host interactome revealed directly from infected cells

Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines

Structural basis of receptor recognition by SARS-CoV-2

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

Exosomes

Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization

Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein

Mucosal Immunity in the Female Genital Tract, HIV/AIDS

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development

Germline‐targeting immunogens

Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles

Development of prophylactic vaccines against HIV-1

Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies

Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design

Comparison of Neutralizing Antibody Responses Elicited from Highly Diverse Polyvalent Heterotrimeric HIV-1 gp140 Cocktail Immunogens versus a Monovalent Counterpart in Rhesus Macaques

Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques

Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking

High-Multiplicity HIV-1 Infection and Neutralizing Antibody Evasion Mediated by the Macrophage-T Cell Virological Synapse